• DevelopingMagnitude 7 earthquake reported in China; GDACS estimates 10,000 in MMI VII+ area — 2 sources
  • New storyCrash on Dixie Highway in Crestview Hills closes I-275 exit ramp
  • DevelopingNWS warns of severe thunderstorm with 60 mph gusts, large hail in parts of Arizona — 3 sources
  • DevelopingNWS warns of severe thunderstorm with 60 mph gusts, large hail in parts of Arizona — 2 sources
  • DevelopingMagnitude 7 earthquake reported in China; GDACS estimates 10,000 in MMI VII+ area — 1 source
  • New storyNWS warns of severe thunderstorm with 60 mph gusts, large hail in parts of Arizona
  • RenderingHurricane Utah flooding forces Gould Wash and WillowWind evacuations
  • New storyOne dead after crash into tree on Carl Baker Road in Starr, coroner says
  • New storyNWS warns of flash flooding in Fresno area through 6:15 p.m. PDT
  • New storyNWS warns of severe thunderstorm near Solomon with 60 mph gusts and quarter-size hail

Science · Chemistry Nobel

Kagan and Soai win Chemistry Nobel for making molecular handedness count

Their discoveries help chemists favor the intended mirror-image molecule—and show how a tiny imbalance can grow. That matters for medicines, without proving how life acquired its handedness.

Aired Written 7 min read43 sourcesHeyDay News Desk · About usWatch report
Explore with HeyDex

Follow via RSS

Transcript · LOADING

Story trackerDay 1

1 report23 outlets43 sources2 videos

  • No dated events yet
  1. Update 1Kagan and Soai win Chemistry Nobel for making molecular handedness countYou are here

For someone taking a medicine, a molecule’s shape can matter as much as its chemical formula. Two mirror-image versions can interact differently with biology. Making the intended version is therefore not just a question of producing the right ingredients: it is a question of arranging them in the right three-dimensional form. The discoveries honored by this year’s Chemistry Nobel give chemists ways to favor one version—and, in suitable reactions, turn an almost imperceptible preference into an overwhelming one. 1 12

Henri B. Kagan and Kenso Soai have won the 2026 Nobel Prize in Chemistry, announced by the Royal Swedish Academy of Sciences on Wednesday, October 7, in Stockholm. The official citation recognizes them “for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis.” The announcement lists Kagan at Université Paris-Sud in France and Soai at Tokyo University of Science in Japan. 4 5

The total chemistry prize is 12 million Swedish kronor, about $1.2 million, NPR reported. NewKerala reports that the laureates will share it equally; the available official announcement excerpts do not establish that allocation. The 12 million kronor is the total, not an award of that amount to each scientist. 1 15

The practical importance and the deeper scientific puzzle meet at the same question: how does chemistry become strongly one-sided?

Why a mirror image matters

Hold up your hands. They are mirror images, but no amount of turning one will make it match the other in every respect. Certain molecules have the same property. Their mirror-image forms are called enantiomers; asymmetric organic synthesis favors one rather than producing both in equal amounts. Homochirality describes the selection or predominance of one handedness. A chemical formula alone cannot capture that distinction. 12 13

Kagan’s work in the 1980s showed that certain reactions can magnify a preference for one handedness, as BBC science correspondent Pallab Ghosh explained. The imbalance in a catalyst and the imbalance in the resulting product need not increase in simple proportion. In suitable systems, the product can show a stronger preference. That is the non-linear effect—not a rule that every asymmetric reaction amplifies handedness. 2

Soai’s work supplied a self-reinforcing mechanism. In asymmetric autocatalysis, the chiral reaction product itself helps catalyze the production of more of that product. An existing preference can feed back into further production and grow. Instead of merely preserving an initial imbalance, the reaction can strengthen it. 2 26

The published discovery record includes the 1995 Nature paper, Asymmetric autocatalysis and amplification of enantiomeric excess of a chiral molecule, by Soai, Takanori Shibata, Hiroshi Morioka and colleagues. That establishes the subject and year of the publication; it does not place every later amplification result in that first paper. 43

From nearly balanced to overwhelmingly one-sided

A later research description, dated January 22, 2014, gives a striking example. In a system involving 2-alkynylpyrimidyl alkanol, approximately 0.00005 percent initial enantiomeric excess was amplified to more than 99.5 percent enantiomeric excess in the same compound. 28

Key facts

  1. ≈0.00005%Reported initial enantiomeric excess 28
  2. >99.5%Reported final enantiomeric excess 28

The key phrase is enantiomeric excess: it measures the imbalance between the two mirror-image forms. It is not chemical yield, and it does not mean that 99.5 percent of all material used in manufacturing became the desired product. Dividing the reported final threshold by the approximate starting value gives an increase of more than roughly 1.99 million-fold in that measure—not a separately precise experimental amplification factor. 28

The described chemistry uses pyrimidyl alkanol as an asymmetric autocatalyst in the addition of diisopropylzinc to pyrimidine-5-carbaldehyde. The exceptionally small starting imbalance belongs to the specific 2-alkynylpyrimidyl alkanol system, not to an unspecified universal reaction. A July 2002 account also described amplification in reactions involving pyrimidine-, quinoline- and pyridine-carbaldehydes. 28 22

The available descriptions do not identify the original experiment date for the extreme example, its number of reaction cycles or its complete procedure. Those gaps limit a detailed reconstruction. They do not erase the reported result, but they do prevent treating it as a recipe that works under any conditions.

Better reaction design, not blanket safety

The Nobel Committee described the discoveries as decisive for chemists designing reactions to manufacture pharmaceuticals, NPR reported. That is a substantial achievement without inflating it into something else: the award does not announce a new treatment, demonstrate lower drug prices or guarantee safer manufacturing in every process. 1

Familiar drug examples also need care. DW’s October 7 segment placed its thalidomide discussion in the mid-1990s and cited an estimated 20,000 infant deaths. The research description checked here places the disaster in the late 1950s; the death estimate was not verified. Reports of differences between thalidomide’s optical isomers do not establish the simplistic story that one is harmless and the other dangerous, or that selecting a single enantiomer eliminates harm. 3 33 36

The same caution applies to DW’s explanation that only one of ibuprofen’s mirror-image forms has an effect. The available research excerpts do not establish that exclusive-activity claim or the extent of metabolic conversion between forms. The Nobel’s significance does not depend on turning a complicated drug into a tidy good-molecule/bad-molecule illustration. 3 34 39

A mechanism is not life’s history

Committee chair Heiner Linke described the discoveries as providing a solution to the century-old mystery of how homochirality can emerge spontaneously, according to NPR. His assessment concerns a route by which a strong molecular preference can develop. It should not be stretched into proof of the actual historical origin of biological handedness. 1

Demonstrating amplification in a laboratory is different from showing that this particular reaction occurred before life emerged, or explaining why biology selected a particular handedness. The Soai system is a tool for examining possibilities, not a demonstrated reconstruction of life’s beginnings. 28

That boundary leaves the achievement intact. Kagan and Soai showed that chemistry need not simply accept the balance it starts with. In appropriate systems, reactions can favor a desired mirror-image product and magnify a minute preference. For pharmaceutical reaction design, that is useful control. For understanding life’s handedness, it is a demonstrated possibility—not the final historical answer.

Sources and supporting research

NPR: Henri B. Kagan and Kenso Soai win Nobel Prize in chemistry. 1

BBC News: October 7 Global News Podcast, chemistry segment. 2

DW News: Why this Chemistry Nobel matters for modern medicine. 3

Royal Swedish Academy of Sciences: The Nobel Prize in Chemistry 2026. 4

NobelPrize.org: English press release. 5

Academy: Scientific Background. 6

NobelPrize.org: press-release PDF. 7

Academy: They solved chemistry’s asymmetric mystery. 8

Academy: press-release PDF. 9

NobelPrize.org: Swedish press release. 10

Science: Nobel Prize honors researchers who solved chemistry’s asymmetry mystery. 11

NobelPrize.org: Popular information. 12

Academy: Popular Science Background. 13

Royal Society of Chemistry: Henri Kagan and Kenso Soai win 2026 Chemistry Nobel Prize. 14

NewKerala: Nobel Chemistry 2026: Kagan, Soai win for mirror-molecule work. 15

NobelPrize.org: Scientific Background PDF. 16

Nature Communications: Mechanistic analysis and kinetic profiling of Soai’s asymmetric autocatalysis for pyridyl and pyrimidyl substrates. 17

NobelPrize.org: Popular Science Background PDF. 18

Chemistry World: Explainer on autocatalysis and non-linear effects. 19

Heise: How homochirality arises from a hint of asymmetry. 20

Asymmetric Autocatalysis of Pyrimidyl Alkanol and Its Application to the Study on the Origin of Homochirality. 21

Asymmetric autocatalysis and its application to chiral discrimination. 22

Tokyo University of Science-hosted Soai Research Work document. 23

Publication record: Asymmetric autocatalysis and amplification of enantiomeric excess of a chiral molecule. 24

Discovery and Development of Asymmetric Autocatalysis, publisher record. 25

Discovery and Development of Asymmetric Autocatalysis, research description. 26

Asymmetric Autocatalysis and Homochirality of Biomolecules. 27

The Origins of Homochirality Examined by Using Asymmetric Autocatalysis. 28

Tokyo University of Science-hosted Asymmetric autocatalysis and the origin of homochirality of biomolecules. 29

Asymmetric autocatalysis and the origin of chiral homogeneity in organic compounds. 30

Heise: Nobel Prize in Chemistry for the discovery of nonlinear effects. 31

Boston Globe: Nobel Prize in chemistry awarded to Henri Kagan and Kenso Soai. 32

Scientific Reports: Understanding the Thalidomide Chirality in Biological Processes by the Self-disproportionation of Enantiomers. 33

Pharmacodynamics and Pharmacokinetics of the Profens, with special reference to S(+)-ibuprofen. 34

Chirality: Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of thalidomide enantiomers. 35

Structural basis of thalidomide enantiomer binding to cereblon. 36

J-STAGE-hosted Chemical and Pharmaceutical Bulletin PDF. 37

PNAS: Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs. 38

The relationship between ibuprofen-enantiomer pharmacokinetics and racemic ibuprofen dose in humans. 39

Stereointegrity of thalidomide: gas-chromatographic determination of the enantiomerization barrier. 40

Death and Rebirth of the Thalidomide Molecule. 41

Chirality: The Stereoselective Pharmacokinetics of Ibuprofen Enantiomers in Mice, Guinea Pigs, and Rats. 42

Soai and colleagues, Nature, 1995: Asymmetric autocatalysis and amplification of enantiomeric excess of a chiral molecule. 43

As aired 21 lines
  1. A chemical reaction produced more than 99.5 percent excess of one mirror-image molecular form. Henri B. Kagan and Kenso Soai have won the 2026 Chemistry Nobel for discoveries that connect that amplification to designing pharmaceutical reactions. How can a tiny molecular preference become overwhelming, and what does that establish about life’s handedness?
  2. Kagan showed that certain reactions can magnify a preference for one molecular handedness. Soai identified a self-reinforcing reaction in which the product helps make more of itself. Together, those discoveries give chemists ways to favor a desired mirror-image product.
  3. The confirmed names are Henri B. Kagan and Kenso Soai. Enrique Kagan, Keno Soy and Kenso Soy are mistaken versions, not additional recipients or established alternative names. Their listed university affiliations belong to the award announcement; they do not establish a dated history of appointments.
  4. The award was announced on October 7, 2026, in Stockholm. Kagan’s listed affiliation is Université Paris-Sud in France, associated with Orsay. Soai’s is Tokyo University of Science in Japan. The recognition spans decades of chemistry, rather than a newly launched medicine.
  5. The award recognizes non-linear effects and autocatalysis in asymmetric organic synthesis. That means controlling which mirror-image molecular form a reaction favors. It does not declare that the historical origin of biological handedness has been proved.
  6. Two molecules can share a chemical formula yet differ in their three-dimensional arrangement. When they are mirror images that cannot be superimposed, they are called enantiomers. Biology can distinguish between them, so a medicine’s formula alone does not tell the whole story of its behavior.
  7. Left and right hands provide the useful analogy: mirror images, but not interchangeable arrangements. Asymmetric synthesis favors one molecular form instead of making both in equal amounts. Homochirality describes the selection or predominance of one handedness.
  8. Kagan’s work in the 1980s showed that the imbalance in a catalyst and the imbalance in its product need not increase in simple proportion. In suitable reactions, the product can have a stronger preference for one handedness. That is the non-linear effect. It does not mean every asymmetric reaction amplifies handedness. A specific 1986 discovery date and original paper title remain unverified.
  9. Soai’s published discovery record includes a paper dated December 1, 1995. A July 2002 account described amplification in reactions involving pyrimidine-, quinoline- and pyridine-carbaldehydes. Those publication records do not establish that the later extreme result appeared in the first paper.
  10. Soai’s feedback mechanism is asymmetric autocatalysis: the chiral product itself helps catalyze production of more of that product. An existing preference can feed back into further production and grow. In the described chemical system, pyrimidyl alkanol acts as the asymmetric autocatalyst in the addition of diisopropylzinc to pyrimidine-5-carbaldehyde.
  11. The exceptionally small starting imbalance concerns a specific compound, 2-alkynylpyrimidyl alkanol. It is not a result for an unspecified universal reaction. The striking numbers belong to a later research description dated January 22, 2014, rather than quantities established by the available 1995 paper record.
  12. In that 2-alkynylpyrimidyl alkanol system, approximately 0.00005 percent initial enantiomeric excess was amplified to more than 99.5 percent enantiomeric excess in the same compound. A tiny initial preference became a very strong one through asymmetric autocatalysis.
  13. Enantiomeric excess measures the imbalance between the two mirror-image forms. It is not chemical yield, and it is not the percentage of all material manufactured. Dividing the final threshold by the nominal starting value gives more than roughly 1.99 million-fold amplification in that measure. Because the starting value is approximate, that ratio is not a separately precise experimental measurement.
  14. The original experimental date, reaction-cycle count and full procedure remain unidentified. Exact substituents, quantities, solvent, temperature and analytical methods are also missing. Those gaps limit a detailed reconstruction of the experiment; they do not erase the stated amplification result.
  15. The pharmaceutical consequence is a way to design reactions that favor the intended molecular form. It is not a demonstrated reduction in drug prices, a new treatment, or a guarantee that every manufacturing process becomes safer. The Nobel recognizes discoveries and mechanisms, not those downstream outcomes.
  16. The chemistry prize totals 12 million Swedish kronor, about 1.2 million dollars. That is the total award, not 12 million kronor for each scientist. An equal split remains unconfirmed, and individual monetary allocations are not independently established.
  17. Thalidomide shows why familiar drug examples require care. Its disaster belongs to the late 1950s, not the mid-1990s. The asserted figure of 20,000 infant deaths is not verified. Differences between its optical isomers in pharmacological and toxicological activity are described, including an association of the S form with teratogenicity—harm to fetal development.
  18. That does not establish that the R form is harmless or exclusively therapeutic. Nor does it support a promise that selecting one thalidomide enantiomer eliminates harm. The relevant bodily interconversion results and mechanism remain unestablished in the available evidence.
  19. The same caution applies to ibuprofen. The claim that tablets contain equal amounts of two mirror-image forms and only one has an effect is not established here. Neither the asserted exclusive activity nor the extent of metabolic conversion between forms can serve as a settled explanation of this Nobel achievement.
  20. A chemical mechanism can explain how a strong handedness preference can emerge spontaneously. That is different from demonstrating that this particular laboratory reaction occurred before life emerged, or explaining why biology selected a particular handedness. The Soai system examines possibilities; it does not reconstruct life’s origin.
  21. The discoveries establish how suitable chemical reactions can favor one mirror-image product and amplify a minute initial imbalance into a large one. The actual historical route by which life acquired its molecular handedness remains distinct from what this award establishes.

Sources

43 sources23 outlets2 videos2 wire copies

Source map

Follow the evidence behind this report. The map shows its connections; the links below open the sources cited in this article.

Source map loads as you read.

Explore the full newsroom map ↗

Revision log

  1. r1First published.